XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the ...

Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcherCritical unmet need: 1 in 31 ...

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with ...

Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA ...
The Scientist

Glutamatergic Synapses Act as a Hub for Intellectual Disability

Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...